SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019459
Filing Date
2018-08-06
Accepted
2018-08-06 16:34:09
Documents
51
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-10q_20180630.htm 10-Q 1571824
2 EX-31.1 rcus-ex311_11.htm EX-31.1 17673
3 EX-31.2 rcus-ex312_7.htm EX-31.2 17735
4 EX-32.1 rcus-ex321_8.htm EX-32.1 9190
5 EX-32.2 rcus-ex322_9.htm EX-32.2 9221
  Complete submission text file 0001564590-18-019459.txt   5023019

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rcus-20180630.xml EX-101.INS 1003508
7 XBRL TAXONOMY EXTENSION SCHEMA rcus-20180630.xsd EX-101.SCH 36380
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcus-20180630_cal.xml EX-101.CAL 39513
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcus-20180630_def.xml EX-101.DEF 101039
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20180630_lab.xml EX-101.LAB 280913
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20180630_pre.xml EX-101.PRE 205099
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 18995187
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences